Characterization of GGAA-microsatellites provides insight in the role of noncoding DNA in cancer susceptibility and therapeutic development.
The Head Start 4 clinical trial introduces risk stratification and builds on the success of bone marrow transplantation for young children with malignant embryonal tumors.
Researchers describe how the association of the EWS/FLI transcription factor with GGAA-microsatellites drives Ewing sarcoma.
Despite guidelines that advocate watching and waiting, physicians are still treating most patients with immune thrombocytopenia.
Collaboration and innovative thinking result in a new technology platform to improve the patient experience.
Profiling reveals histologic subtype distinctions and heterogeneity of neurofibromatosis type 1-associated tumors.
Recent study results suggest that combining virotherapy and PD-1 blockades may be more effective than either approach alone.
